405 results on '"Navarro-González, Juan F."'
Search Results
2. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care
3. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica
4. Proyección de la carga clínica y económica de la enfermedad renal crónica entre 2022 y 2027 en España: resultados del proyecto Inside CKD
5. Consensus document on the management of hyperkalemia
6. Documento de consenso sobre el abordaje de la hiperpotasemia
7. Targeting inflammation to treat diabetic kidney disease: the road to 2030
8. #2775 ERCOS multicenter Spanish study: clinical profile of patients with chronic kidney disease G3a-G5D and osteoporosis
9. #2009 FGF23 in patients with diabetic kidney disease and atherosclerosis
10. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
11. Bodas de plata: 25 años de la primera demostración del efecto directo del fósforo en la célula paratiroidea
12. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study
13. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease
14. Reply to "Letter to the Editor — Consensus document on the management of hyperkalaemia"
15. Bases para la creación de las unidades clínicas cardiorrenales. Documento de consenso de los grupos de trabajo cardiorrenal de la SEC y la SEN
16. Developing the subspecialty of cardio-nephrology: The time has come. A position paper from the coordinating committee from the Working Group for Cardiorenal Medicine of the Spanish Society of Nephrology
17. Interleukin-17A: Potential mediator and therapeutic target in hypertension
18. Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión
19. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.
20. Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease
21. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
22. Respuesta a 202309 Carta al Director consenso HK 2023
23. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study
24. Inflammation and reduced hemoglobin levels are differentially associated with coronary artery disease in non-albuminuric subjects with and without type 2 diabetes mellitus
25. Anti-inflammatory profile of paricalcitol in kidney transplant recipients
26. Perfil antiinflamatorio del paricalcitol en el receptor de trasplante renal
27. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis
28. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities
29. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis
30. #3195 PATIENTS ON HD WITH CENTRAL CATHETERS LOCKED WITH TAUROLIDINE HAVE A SIMILAR INFLAMMATORY PROFILE TO SUBJECTS WITH NATIVE ARTERIOVENOUS FISTULA
31. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study
32. Manejo de la osteoporosis en el paciente con enfermedad renal crónica (Estudio ERCOS): un desafío en la asistencia nefrológica
33. Vitamin D and Inflammation in Chronic Kidney Disease
34. Reply to "Letter to the Editor — Consensus document on the management of hyperkalaemia"
35. Respuesta a «Carta al Director - Documento de consenso sobre el abordaje de la hiperpotasemia»
36. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment
37. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
38. Silver jubilee: 25 years of the first demonstration of the direct effect of phosphate on the parathyroid cell
39. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease
40. Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes
41. Diabetic nephropathy is an independent factor associated to severe subclinical atheromatous disease
42. Serum Phosphate Levels Modify the Impact of FGF23 Levels on Hemoglobin in Chronic Kidney Disease
43. The Value of Klotho in Kidney Transplantation
44. Correction to: From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
45. List of Contributors
46. Cytokines in Diabetes and Diabetic Complications
47. Klotho inversely relates with carotid intima-media thickness in atherosclerotic patients with normal renal function (eGFR =60 mL/min/1.73m²): a proof-ofconcept study.
48. Repurposing drugs for highly prevalent diseases: pentoxifylline, an old drug and a new opportunity for diabetic kidney disease
49. MO640: Treatment with Sodium–Glucose Cotransporter 2 Inhibitors Increases Klotho in Type 2 Diabetic Patients
50. From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.